

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.13613949 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.13613949 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.36260458 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.34634728 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.21487049 |
| 6 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.98483541 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.95535190 |
| 8 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.91256926 |
| 9 | DNA deamination (GO:0045006) | 4.77216136 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.72457142 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.42851110 |
| 12 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.12271855 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.07012115 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 4.06121271 |
| 15 | regulation of B cell differentiation (GO:0045577) | 3.99816475 |
| 16 | mannose metabolic process (GO:0006013) | 3.89795616 |
| 17 | response to interferon-beta (GO:0035456) | 3.83924165 |
| 18 | response to interferon-alpha (GO:0035455) | 3.54297202 |
| 19 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.52229663 |
| 20 | positive thymic T cell selection (GO:0045059) | 3.51247530 |
| 21 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.43880265 |
| 22 | positive regulation of B cell differentiation (GO:0045579) | 3.41517143 |
| 23 | type I interferon signaling pathway (GO:0060337) | 3.29662162 |
| 24 | cellular response to type I interferon (GO:0071357) | 3.29662162 |
| 25 | positive regulation of lamellipodium organization (GO:1902745) | 3.28606603 |
| 26 | positive regulation of lamellipodium assembly (GO:0010592) | 3.28285508 |
| 27 | response to type I interferon (GO:0034340) | 3.27622838 |
| 28 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.26773488 |
| 29 | leukocyte aggregation (GO:0070486) | 3.26760481 |
| 30 | B cell receptor signaling pathway (GO:0050853) | 3.24473331 |
| 31 | response to interleukin-15 (GO:0070672) | 3.23422670 |
| 32 | B cell mediated immunity (GO:0019724) | 3.22628331 |
| 33 | valine metabolic process (GO:0006573) | 3.22481949 |
| 34 | cellular response to interferon-beta (GO:0035458) | 3.22306092 |
| 35 | platelet dense granule organization (GO:0060155) | 3.19731812 |
| 36 | T cell selection (GO:0045058) | 3.19395249 |
| 37 | positive regulation by symbiont of host defense response (GO:0052509) | 3.18091260 |
| 38 | modulation by symbiont of host defense response (GO:0052031) | 3.18091260 |
| 39 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.18091260 |
| 40 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.18091260 |
| 41 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.18091260 |
| 42 | modulation by symbiont of host immune response (GO:0052553) | 3.18091260 |
| 43 | galactose catabolic process (GO:0019388) | 3.17871036 |
| 44 | positive regulation of interferon-alpha production (GO:0032727) | 3.15726424 |
| 45 | maturation of SSU-rRNA (GO:0030490) | 3.13843966 |
| 46 | immunoglobulin mediated immune response (GO:0016064) | 3.12198426 |
| 47 | pentose-phosphate shunt (GO:0006098) | 3.09215765 |
| 48 | positive regulation of tolerance induction (GO:0002645) | 3.08360535 |
| 49 | regulation of response to interferon-gamma (GO:0060330) | 3.07521430 |
| 50 | ribosomal small subunit assembly (GO:0000028) | 3.03877903 |
| 51 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.02290578 |
| 52 | negative regulation of fatty acid transport (GO:2000192) | 3.02219145 |
| 53 | histone H3-K36 demethylation (GO:0070544) | 3.01989171 |
| 54 | positive T cell selection (GO:0043368) | 3.00140175 |
| 55 | mature B cell differentiation involved in immune response (GO:0002313) | 2.97638747 |
| 56 | negative regulation of innate immune response (GO:0045824) | 2.94138993 |
| 57 | regulation of interferon-alpha production (GO:0032647) | 2.92693946 |
| 58 | viral transcription (GO:0019083) | 2.92043760 |
| 59 | actin nucleation (GO:0045010) | 2.88408012 |
| 60 | T cell homeostasis (GO:0043029) | 2.87737000 |
| 61 | cytokinetic process (GO:0032506) | 2.85416646 |
| 62 | response to peptidoglycan (GO:0032494) | 2.85348021 |
| 63 | natural killer cell differentiation (GO:0001779) | 2.84665160 |
| 64 | negative regulation of interleukin-12 production (GO:0032695) | 2.84089901 |
| 65 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.83658079 |
| 66 | regulation of extracellular matrix disassembly (GO:0010715) | 2.83281582 |
| 67 | negative thymic T cell selection (GO:0045060) | 2.82950113 |
| 68 | negative regulation of phagocytosis (GO:0050765) | 2.82670433 |
| 69 | response to muramyl dipeptide (GO:0032495) | 2.81205618 |
| 70 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.80699707 |
| 71 | Peyers patch development (GO:0048541) | 2.80699707 |
| 72 | mature B cell differentiation (GO:0002335) | 2.77961568 |
| 73 | thymic T cell selection (GO:0045061) | 2.76226919 |
| 74 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.75820830 |
| 75 | regulation of monocyte differentiation (GO:0045655) | 2.74499014 |
| 76 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.72310932 |
| 77 | negative regulation of cell killing (GO:0031342) | 2.72310932 |
| 78 | translational termination (GO:0006415) | 2.71061673 |
| 79 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.70307507 |
| 80 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.68540145 |
| 81 | negative T cell selection (GO:0043383) | 2.67681495 |
| 82 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.66495799 |
| 83 | detection of other organism (GO:0098543) | 2.66494252 |
| 84 | megakaryocyte development (GO:0035855) | 2.65984397 |
| 85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.65135775 |
| 86 | NIK/NF-kappaB signaling (GO:0038061) | 2.64947504 |
| 87 | necroptotic process (GO:0070266) | 2.64349200 |
| 88 | negative regulation of T cell mediated immunity (GO:0002710) | 2.64270836 |
| 89 | tolerance induction (GO:0002507) | 2.63752292 |
| 90 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.63342483 |
| 91 | regulation of tolerance induction (GO:0002643) | 2.62559811 |
| 92 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.62496770 |
| 93 | detection of bacterium (GO:0016045) | 2.61212899 |
| 94 | response to laminar fluid shear stress (GO:0034616) | 2.60587869 |
| 95 | defense response to protozoan (GO:0042832) | 2.60261518 |
| 96 | NADPH regeneration (GO:0006740) | 2.60229385 |
| 97 | cellular response to dsRNA (GO:0071359) | 2.59260020 |
| 98 | lymph node development (GO:0048535) | 2.58607380 |
| 99 | barbed-end actin filament capping (GO:0051016) | 2.58397277 |
| 100 | activated T cell proliferation (GO:0050798) | 2.57716865 |
| 101 | cellular response to interleukin-15 (GO:0071350) | 2.57643638 |
| 102 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.56273580 |
| 103 | macrophage activation involved in immune response (GO:0002281) | 2.55814191 |
| 104 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.54716483 |
| 105 | histone H3-K4 trimethylation (GO:0080182) | 2.54702595 |
| 106 | cellular extravasation (GO:0045123) | 2.54315576 |
| 107 | regulation of respiratory burst (GO:0060263) | 2.54023515 |
| 108 | germinal center formation (GO:0002467) | 2.52881621 |
| 109 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.52081794 |
| 110 | protein targeting to ER (GO:0045047) | 2.51410452 |
| 111 | response to protozoan (GO:0001562) | 2.49076221 |
| 112 | cotranslational protein targeting to membrane (GO:0006613) | 2.48980823 |
| 113 | positive regulation of Rap GTPase activity (GO:0032854) | 2.47742154 |
| 114 | translational elongation (GO:0006414) | 2.47383371 |
| 115 | protein localization to endosome (GO:0036010) | 2.46867941 |
| 116 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.46604461 |
| 117 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.46533720 |
| 118 | positive regulation of granulocyte differentiation (GO:0030854) | 2.46368094 |
| 119 | macrophage differentiation (GO:0030225) | 2.45141284 |
| 120 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.44507306 |
| 121 | regulation of ARF protein signal transduction (GO:0032012) | 2.44245948 |
| 122 | tricarboxylic acid metabolic process (GO:0072350) | 2.43970392 |
| 123 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.43866821 |
| 124 | protein localization to endoplasmic reticulum (GO:0070972) | 2.43011143 |
| 125 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.42805002 |
| 126 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.42805002 |
| 127 | regulation of erythrocyte differentiation (GO:0045646) | 2.40764897 |
| 128 | regulation of natural killer cell differentiation (GO:0032823) | 2.40635058 |
| 129 | regulation of necroptotic process (GO:0060544) | 2.39951876 |
| 130 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.39539686 |
| 131 | endosome to pigment granule transport (GO:0043485) | 2.37578838 |
| 132 | endosome to melanosome transport (GO:0035646) | 2.37578838 |
| 133 | embryonic process involved in female pregnancy (GO:0060136) | 2.35955519 |
| 134 | regulation of histone H3-K27 methylation (GO:0061085) | 2.34255935 |
| 135 | response to host (GO:0075136) | 2.32396275 |
| 136 | response to host defenses (GO:0052200) | 2.32396275 |
| 137 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.32396275 |
| 138 | activation of JUN kinase activity (GO:0007257) | 2.31377316 |
| 139 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.31233647 |
| 140 | hepatocyte apoptotic process (GO:0097284) | 2.31109223 |
| 141 | macroautophagy (GO:0016236) | 2.30557377 |
| 142 | interferon-gamma secretion (GO:0072643) | 2.29399784 |
| 143 | regulation of granulocyte differentiation (GO:0030852) | 2.28284938 |
| 144 | negative regulation of granulocyte differentiation (GO:0030853) | 2.27495066 |
| 145 | regulation of T cell tolerance induction (GO:0002664) | 2.23621055 |
| 146 | detection of external biotic stimulus (GO:0098581) | 2.20112565 |
| 147 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.20065890 |
| 148 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.18240626 |
| 149 | regulation of defense response to virus by virus (GO:0050690) | 2.17997689 |
| 150 | striated muscle atrophy (GO:0014891) | 2.16549938 |
| 151 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.15469733 |
| 152 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.15319144 |
| 153 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.14357906 |
| 154 | B cell homeostasis (GO:0001782) | 2.13953988 |
| 155 | stress fiber assembly (GO:0043149) | 2.12661115 |
| 156 | regulation of leukocyte degranulation (GO:0043300) | 2.10956993 |
| 157 | regulation of extracellular matrix organization (GO:1903053) | 2.10435274 |
| 158 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.09537347 |
| 159 | positive regulation of histone deacetylation (GO:0031065) | 2.09494300 |
| 160 | positive regulation of extracellular matrix organization (GO:1903055) | 2.07472791 |
| 161 | T cell migration (GO:0072678) | 2.06496320 |
| 162 | growth hormone receptor signaling pathway (GO:0060396) | 2.04545172 |
| 163 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.03772243 |
| 164 | cell-substrate adherens junction assembly (GO:0007045) | 2.03612912 |
| 165 | focal adhesion assembly (GO:0048041) | 2.03612912 |
| 166 | ear development (GO:0043583) | 2.02918980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.75556333 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.19214036 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.00343127 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.89343313 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.80855879 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.79694317 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.78967428 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.77838615 |
| 9 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.64992308 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.56694400 |
| 11 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.52357816 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.46262167 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.45925033 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.36766811 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.33763266 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.31270465 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.23929976 |
| 18 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23006841 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.20734326 |
| 20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16540261 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.16454246 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.13592670 |
| 23 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.09928647 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04770912 |
| 25 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.97487275 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.95276389 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92928506 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.92207582 |
| 29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.91633923 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.90723027 |
| 31 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87877553 |
| 32 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85308490 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82307704 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.82302211 |
| 35 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.82206084 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81979166 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.81353667 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80539309 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.79459512 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78093577 |
| 41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76313146 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.75567079 |
| 43 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.75314343 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.71711024 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69994393 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.67218198 |
| 47 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.67130354 |
| 48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.67048002 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.65407502 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.59756275 |
| 51 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.56033817 |
| 52 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.55923176 |
| 53 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.55224862 |
| 54 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54786166 |
| 55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.54648438 |
| 56 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.54130782 |
| 57 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.52953863 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.52865742 |
| 59 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.52305547 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51792606 |
| 61 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.50763559 |
| 62 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.50099815 |
| 63 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.48930293 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47488414 |
| 65 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.46671134 |
| 66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44861388 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.44390865 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43952783 |
| 69 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42087157 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42014367 |
| 71 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.41995868 |
| 72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41846371 |
| 73 | MAF_26560356_Chip-Seq_TH2_Human | 1.40572369 |
| 74 | KDM2B_26808549_Chip-Seq_K562_Human | 1.40280288 |
| 75 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.40138412 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39905221 |
| 77 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.38271258 |
| 78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37807771 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36073892 |
| 80 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.34738211 |
| 81 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.32886265 |
| 82 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32440459 |
| 83 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.32336915 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32257548 |
| 85 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.31992352 |
| 86 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31967948 |
| 87 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.31222507 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29931380 |
| 89 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.29606379 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27729213 |
| 91 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.27610257 |
| 92 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.27524266 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27049592 |
| 94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26961467 |
| 95 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.26894264 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25771128 |
| 97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25714221 |
| 98 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21633739 |
| 99 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17666229 |
| 100 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.17166056 |
| 101 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16427145 |
| 102 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.16368726 |
| 103 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16034624 |
| 104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15887430 |
| 105 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.15403101 |
| 106 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15045827 |
| 107 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.14721017 |
| 108 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14071277 |
| 109 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.11921266 |
| 110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11737611 |
| 111 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11595235 |
| 112 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11173246 |
| 113 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.11043668 |
| 114 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10650180 |
| 115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10356770 |
| 116 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.09828885 |
| 117 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.09617560 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.08385177 |
| 119 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08348068 |
| 120 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07811644 |
| 121 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07649745 |
| 122 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07256530 |
| 123 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.05569216 |
| 124 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.05243406 |
| 125 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04117290 |
| 126 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03999717 |
| 127 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03769194 |
| 128 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.02974654 |
| 129 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02896291 |
| 130 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02318972 |
| 131 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01113631 |
| 132 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.00550841 |
| 133 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.00550841 |
| 134 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00484538 |
| 135 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.00443941 |
| 136 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99876587 |
| 137 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.99686862 |
| 138 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.99686862 |
| 139 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99584964 |
| 140 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.99323920 |
| 141 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99312971 |
| 142 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98644140 |
| 143 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98387922 |
| 144 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98327502 |
| 145 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.97501348 |
| 146 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97275090 |
| 147 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97055900 |
| 148 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.96775043 |
| 149 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.95259165 |
| 150 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95107166 |
| 151 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.93829891 |
| 152 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93562665 |
| 153 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93436000 |
| 154 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.93226899 |
| 155 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93023738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.59596162 |
| 2 | MP0000685_abnormal_immune_system | 3.45528571 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.36417540 |
| 4 | MP0009785_altered_susceptibility_to | 3.23977407 |
| 5 | MP0003763_abnormal_thymus_physiology | 3.15579811 |
| 6 | MP0005671_abnormal_response_to | 2.67172529 |
| 7 | MP0005025_abnormal_response_to | 2.49475912 |
| 8 | MP0002254_reproductive_system_inflammat | 2.43222768 |
| 9 | MP0003436_decreased_susceptibility_to | 2.41496877 |
| 10 | MP0003724_increased_susceptibility_to | 2.41433753 |
| 11 | MP0001800_abnormal_humoral_immune | 2.35712579 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.32757007 |
| 13 | MP0002723_abnormal_immune_serum | 2.31124736 |
| 14 | MP0005409_darkened_coat_color | 2.27585709 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.25884474 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.24854175 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.23508537 |
| 18 | MP0001819_abnormal_immune_cell | 2.22671273 |
| 19 | MP0002398_abnormal_bone_marrow | 2.19393385 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.17867874 |
| 21 | MP0002419_abnormal_innate_immunity | 2.17560908 |
| 22 | MP0001873_stomach_inflammation | 2.14817627 |
| 23 | MP0001790_abnormal_immune_system | 2.06927041 |
| 24 | MP0005387_immune_system_phenotype | 2.06927041 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.06824701 |
| 26 | MP0003091_abnormal_cell_migration | 2.04233711 |
| 27 | MP0001958_emphysema | 2.03707049 |
| 28 | MP0004381_abnormal_hair_follicle | 2.01427856 |
| 29 | MP0006054_spinal_hemorrhage | 1.99829968 |
| 30 | MP0000465_gastrointestinal_hemorrhage | 1.99323434 |
| 31 | MP0005076_abnormal_cell_differentiation | 1.97893216 |
| 32 | MP0000716_abnormal_immune_system | 1.96444976 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.90327069 |
| 34 | MP0002722_abnormal_immune_system | 1.88612656 |
| 35 | MP0002166_altered_tumor_susceptibility | 1.88079973 |
| 36 | MP0010234_abnormal_vibrissa_follicle | 1.85694137 |
| 37 | MP0004947_skin_inflammation | 1.84673590 |
| 38 | MP0002405_respiratory_system_inflammati | 1.82505720 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.82348277 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.79747545 |
| 41 | MP0002009_preneoplasia | 1.78355080 |
| 42 | MP0003303_peritoneal_inflammation | 1.75768712 |
| 43 | MP0002429_abnormal_blood_cell | 1.74298351 |
| 44 | MP0001853_heart_inflammation | 1.72921035 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.71887721 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.71008554 |
| 47 | MP0003828_pulmonary_edema | 1.70346906 |
| 48 | MP0009840_abnormal_foam_cell | 1.70188728 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.68813122 |
| 50 | MP0002139_abnormal_hepatobiliary_system | 1.68562866 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.65932992 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.65932992 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.63650016 |
| 54 | MP0008469_abnormal_protein_level | 1.62637560 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.62372444 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.58799815 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.57727741 |
| 58 | MP0004130_abnormal_muscle_cell | 1.56575124 |
| 59 | MP0010368_abnormal_lymphatic_system | 1.54716736 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.53267774 |
| 61 | MP0002148_abnormal_hypersensitivity_rea | 1.51886458 |
| 62 | MP0003866_abnormal_defecation | 1.50216436 |
| 63 | MP0004185_abnormal_adipocyte_glucose | 1.48787239 |
| 64 | MP0006082_CNS_inflammation | 1.45985866 |
| 65 | MP0005365_abnormal_bile_salt | 1.45554645 |
| 66 | MP0003011_delayed_dark_adaptation | 1.42200126 |
| 67 | MP0001348_abnormal_lacrimal_gland | 1.41235031 |
| 68 | MP0000490_abnormal_crypts_of | 1.39571173 |
| 69 | MP0003279_aneurysm | 1.39485596 |
| 70 | MP0003453_abnormal_keratinocyte_physiol | 1.37078746 |
| 71 | MP0005360_urolithiasis | 1.35281435 |
| 72 | MP0000858_altered_metastatic_potential | 1.32561573 |
| 73 | MP0004883_abnormal_blood_vessel | 1.32398667 |
| 74 | MP0002006_tumorigenesis | 1.30347327 |
| 75 | MP0004264_abnormal_extraembryonic_tissu | 1.29937993 |
| 76 | MP0000609_abnormal_liver_physiology | 1.29695221 |
| 77 | MP0005451_abnormal_body_composition | 1.28575404 |
| 78 | MP0009278_abnormal_bone_marrow | 1.27730846 |
| 79 | MP0008438_abnormal_cutaneous_collagen | 1.25781577 |
| 80 | MP0000767_abnormal_smooth_muscle | 1.24939872 |
| 81 | MP0001849_ear_inflammation | 1.23815236 |
| 82 | MP0001533_abnormal_skeleton_physiology | 1.23784470 |
| 83 | MP0005174_abnormal_tail_pigmentation | 1.23463498 |
| 84 | MP0002933_joint_inflammation | 1.20090481 |
| 85 | MP0000015_abnormal_ear_pigmentation | 1.19579204 |
| 86 | MP0002796_impaired_skin_barrier | 1.15613413 |
| 87 | MP0005075_abnormal_melanosome_morpholog | 1.15553099 |
| 88 | MP0003045_fibrosis | 1.12545795 |
| 89 | MP0004510_myositis | 1.11260739 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 1.10968751 |
| 91 | MP0009643_abnormal_urine_homeostasis | 1.08301679 |
| 92 | MP0002138_abnormal_hepatobiliary_system | 1.07128033 |
| 93 | MP0001851_eye_inflammation | 1.07115507 |
| 94 | MP0002909_abnormal_adrenal_gland | 1.05596051 |
| 95 | MP0010678_abnormal_skin_adnexa | 1.01408159 |
| 96 | MP0008007_abnormal_cellular_replicative | 1.01334534 |
| 97 | MP0009763_increased_sensitivity_to | 1.00907782 |
| 98 | MP0003943_abnormal_hepatobiliary_system | 1.00432724 |
| 99 | MP0002877_abnormal_melanocyte_morpholog | 0.99596524 |
| 100 | MP0000598_abnormal_liver_morphology | 0.98156899 |
| 101 | MP0008260_abnormal_autophagy | 0.97221128 |
| 102 | MP0005310_abnormal_salivary_gland | 0.97190181 |
| 103 | MP0002928_abnormal_bile_duct | 0.97128093 |
| 104 | MP0005220_abnormal_exocrine_pancreas | 0.96843196 |
| 105 | MP0002019_abnormal_tumor_incidence | 0.94915650 |
| 106 | MP0000371_diluted_coat_color | 0.93221962 |
| 107 | MP0005164_abnormal_response_to | 0.92961979 |
| 108 | MP0010329_abnormal_lipoprotein_level | 0.92579249 |
| 109 | MP0003183_abnormal_peptide_metabolism | 0.92334359 |
| 110 | MP0003806_abnormal_nucleotide_metabolis | 0.92080343 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.91889915 |
| 112 | MP0009764_decreased_sensitivity_to | 0.90406637 |
| 113 | MP0005375_adipose_tissue_phenotype | 0.90392918 |
| 114 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90041587 |
| 115 | MP0005275_abnormal_skin_tensile | 0.89982326 |
| 116 | MP0000383_abnormal_hair_follicle | 0.88687811 |
| 117 | MP0001764_abnormal_homeostasis | 0.86907987 |
| 118 | MP0000427_abnormal_hair_cycle | 0.86570412 |
| 119 | MP0005167_abnormal_blood-brain_barrier | 0.84234140 |
| 120 | MP0009384_cardiac_valve_regurgitation | 0.83393309 |
| 121 | MP0002998_abnormal_bone_remodeling | 0.82422444 |
| 122 | MP0005023_abnormal_wound_healing | 0.82243391 |
| 123 | MP0005332_abnormal_amino_acid | 0.81158344 |
| 124 | MP0002089_abnormal_postnatal_growth/wei | 0.80917415 |
| 125 | MP0001661_extended_life_span | 0.80323237 |
| 126 | MP0008875_abnormal_xenobiotic_pharmacok | 0.80095844 |
| 127 | MP0000470_abnormal_stomach_morphology | 0.79111582 |
| 128 | MP0008961_abnormal_basal_metabolism | 0.78900174 |
| 129 | MP0009115_abnormal_fat_cell | 0.78405083 |
| 130 | MP0001879_abnormal_lymphatic_vessel | 0.77368445 |
| 131 | MP0000377_abnormal_hair_follicle | 0.76971415 |
| 132 | MP0005390_skeleton_phenotype | 0.76688988 |
| 133 | MP0005085_abnormal_gallbladder_physiolo | 0.76523026 |
| 134 | MP0009780_abnormal_chondrocyte_physiolo | 0.76443637 |
| 135 | MP0003075_altered_response_to | 0.76140209 |
| 136 | MP0001216_abnormal_epidermal_layer | 0.75728829 |
| 137 | MP0000477_abnormal_intestine_morphology | 0.75283154 |
| 138 | MP0002136_abnormal_kidney_physiology | 0.74413242 |
| 139 | MP0000343_altered_response_to | 0.73300511 |
| 140 | MP0009642_abnormal_blood_homeostasis | 0.70631108 |
| 141 | MP0002693_abnormal_pancreas_physiology | 0.70170663 |
| 142 | MP0000313_abnormal_cell_death | 0.68246230 |
| 143 | MP0000249_abnormal_blood_vessel | 0.67976364 |
| 144 | MP0005084_abnormal_gallbladder_morpholo | 0.66997216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.74392720 |
| 2 | IgM deficiency (HP:0002850) | 4.62107748 |
| 3 | Thrombocytosis (HP:0001894) | 3.89924144 |
| 4 | Reticulocytopenia (HP:0001896) | 3.74634360 |
| 5 | Myositis (HP:0100614) | 3.74458726 |
| 6 | Recurrent abscess formation (HP:0002722) | 3.65201826 |
| 7 | Spontaneous hematomas (HP:0007420) | 3.46430091 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 3.36946136 |
| 9 | Abnormality of the nasal mucosa (HP:0000433) | 3.36775393 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.30132990 |
| 11 | Chronic otitis media (HP:0000389) | 3.23704536 |
| 12 | Fatigue (HP:0012378) | 3.14488878 |
| 13 | Recurrent bronchitis (HP:0002837) | 3.05169660 |
| 14 | Arterial tortuosity (HP:0005116) | 3.02666203 |
| 15 | Eczematoid dermatitis (HP:0000976) | 2.97674468 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 2.95762862 |
| 17 | Thin bony cortex (HP:0002753) | 2.93333412 |
| 18 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.88277475 |
| 19 | Lymphopenia (HP:0001888) | 2.86230243 |
| 20 | Nasal polyposis (HP:0100582) | 2.86124130 |
| 21 | Vascular tortuosity (HP:0004948) | 2.85737364 |
| 22 | Abnormality of T cell physiology (HP:0011840) | 2.84892127 |
| 23 | Interstitial pulmonary disease (HP:0006530) | 2.84762067 |
| 24 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.84309411 |
| 25 | Dysostosis multiplex (HP:0000943) | 2.79912183 |
| 26 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.79480787 |
| 27 | Reduced antithrombin III activity (HP:0001976) | 2.78610377 |
| 28 | Abnormality of T cells (HP:0002843) | 2.77835045 |
| 29 | Gastrointestinal inflammation (HP:0004386) | 2.73611001 |
| 30 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.73570439 |
| 31 | Recurrent skin infections (HP:0001581) | 2.71536909 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.70062971 |
| 33 | Recurrent fungal infections (HP:0002841) | 2.66317322 |
| 34 | Inflammation of the large intestine (HP:0002037) | 2.63456517 |
| 35 | Aortic aneurysm (HP:0004942) | 2.58093302 |
| 36 | Petechiae (HP:0000967) | 2.57223777 |
| 37 | Recurrent viral infections (HP:0004429) | 2.57144828 |
| 38 | Colitis (HP:0002583) | 2.56894556 |
| 39 | Pigmentary retinal degeneration (HP:0001146) | 2.56774815 |
| 40 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.56346706 |
| 41 | Panhypogammaglobulinemia (HP:0003139) | 2.56318448 |
| 42 | Broad face (HP:0000283) | 2.50320932 |
| 43 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.41901774 |
| 44 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.40749254 |
| 45 | Orchitis (HP:0100796) | 2.39962345 |
| 46 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.39354476 |
| 47 | Autoimmune hemolytic anemia (HP:0001890) | 2.35948450 |
| 48 | Protrusio acetabuli (HP:0003179) | 2.35935660 |
| 49 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.35483033 |
| 50 | Recurrent cutaneous fungal infections (HP:0011370) | 2.35483033 |
| 51 | Nonimmune hydrops fetalis (HP:0001790) | 2.33362411 |
| 52 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.32637809 |
| 53 | B lymphocytopenia (HP:0010976) | 2.32546608 |
| 54 | Abnormality of B cell number (HP:0010975) | 2.32546608 |
| 55 | Agammaglobulinemia (HP:0004432) | 2.30439405 |
| 56 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.29924083 |
| 57 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.29924083 |
| 58 | Abnormal protein glycosylation (HP:0012346) | 2.29924083 |
| 59 | Abnormal glycosylation (HP:0012345) | 2.29924083 |
| 60 | Aplastic anemia (HP:0001915) | 2.29359299 |
| 61 | Epistaxis (HP:0000421) | 2.29333792 |
| 62 | Acute lymphatic leukemia (HP:0006721) | 2.29323576 |
| 63 | Meningitis (HP:0001287) | 2.28560278 |
| 64 | Prolonged bleeding time (HP:0003010) | 2.28542061 |
| 65 | Increased IgE level (HP:0003212) | 2.27760617 |
| 66 | Mucopolysacchariduria (HP:0008155) | 2.27507561 |
| 67 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27507561 |
| 68 | Abnormal platelet function (HP:0011869) | 2.19823657 |
| 69 | Impaired platelet aggregation (HP:0003540) | 2.19823657 |
| 70 | Abnormality of macrophages (HP:0004311) | 2.19425934 |
| 71 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.18645048 |
| 72 | Spondylolisthesis (HP:0003302) | 2.18416419 |
| 73 | Thoracic kyphosis (HP:0002942) | 2.18252557 |
| 74 | Optic neuritis (HP:0100653) | 2.18242584 |
| 75 | Retrobulbar optic neuritis (HP:0100654) | 2.18242584 |
| 76 | Gastrointestinal infarctions (HP:0005244) | 2.18056436 |
| 77 | T lymphocytopenia (HP:0005403) | 2.17564089 |
| 78 | Cardiomegaly (HP:0001640) | 2.17496475 |
| 79 | Increased cerebral lipofuscin (HP:0011813) | 2.16796441 |
| 80 | Gingivitis (HP:0000230) | 2.15866626 |
| 81 | Type I transferrin isoform profile (HP:0003642) | 2.15596508 |
| 82 | Papilloma (HP:0012740) | 2.14875331 |
| 83 | Verrucae (HP:0200043) | 2.14875331 |
| 84 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.14336900 |
| 85 | Abnormality of T cell number (HP:0011839) | 2.14076746 |
| 86 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.13672103 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.13672103 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.13672103 |
| 89 | Polycythemia (HP:0001901) | 2.13244776 |
| 90 | IgG deficiency (HP:0004315) | 2.13116052 |
| 91 | Cerebral aneurysm (HP:0004944) | 2.12834482 |
| 92 | Progressive neurologic deterioration (HP:0002344) | 2.12240948 |
| 93 | Mitral regurgitation (HP:0001653) | 2.11638167 |
| 94 | Microretrognathia (HP:0000308) | 2.11214843 |
| 95 | Delayed CNS myelination (HP:0002188) | 2.10896581 |
| 96 | Congenital stationary night blindness (HP:0007642) | 2.10254216 |
| 97 | Loss of speech (HP:0002371) | 2.09666816 |
| 98 | Hematochezia (HP:0002573) | 2.09133581 |
| 99 | Dilatation of the ascending aorta (HP:0005111) | 2.08123211 |
| 100 | Subacute progressive viral hepatitis (HP:0006572) | 2.06768287 |
| 101 | Asymmetry of the thorax (HP:0001555) | 2.04163951 |
| 102 | Microcytic anemia (HP:0001935) | 2.03894113 |
| 103 | Albinism (HP:0001022) | 2.03244959 |
| 104 | Obstructive sleep apnea (HP:0002870) | 2.03222975 |
| 105 | Urticaria (HP:0001025) | 2.02592057 |
| 106 | Aneurysm (HP:0002617) | 2.02016117 |
| 107 | Abnormality of the fingertips (HP:0001211) | 2.01879388 |
| 108 | Long toe (HP:0010511) | 2.01747078 |
| 109 | Pustule (HP:0200039) | 2.01105625 |
| 110 | Polygenic inheritance (HP:0010982) | 1.99738108 |
| 111 | Abnormality of DNA repair (HP:0003254) | 1.98572490 |
| 112 | Hyperacusis (HP:0010780) | 1.97435446 |
| 113 | Cellulitis (HP:0100658) | 1.97227945 |
| 114 | Neoplasm of head and neck (HP:0012288) | 1.97080317 |
| 115 | Esophageal neoplasm (HP:0100751) | 1.97080317 |
| 116 | Spinal cord lesions (HP:0100561) | 1.96867207 |
| 117 | Syringomyelia (HP:0003396) | 1.96867207 |
| 118 | Emphysema (HP:0002097) | 1.95789435 |
| 119 | Broad metatarsal (HP:0001783) | 1.95633439 |
| 120 | Vacuolated lymphocytes (HP:0001922) | 1.95398114 |
| 121 | Aortic dissection (HP:0002647) | 1.95326444 |
| 122 | Systemic lupus erythematosus (HP:0002725) | 1.94111192 |
| 123 | Persistence of primary teeth (HP:0006335) | 1.92764958 |
| 124 | J-shaped sella turcica (HP:0002680) | 1.92693880 |
| 125 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.92429259 |
| 126 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.91493075 |
| 127 | Germ cell neoplasia (HP:0100728) | 1.90860872 |
| 128 | Asymmetric septal hypertrophy (HP:0001670) | 1.88671421 |
| 129 | Periodontitis (HP:0000704) | 1.88414811 |
| 130 | Flat acetabular roof (HP:0003180) | 1.88116864 |
| 131 | Posterior subcapsular cataract (HP:0007787) | 1.87380619 |
| 132 | Purpura (HP:0000979) | 1.87342969 |
| 133 | Vasculitis (HP:0002633) | 1.86861136 |
| 134 | Gastrointestinal stroma tumor (HP:0100723) | 1.86349909 |
| 135 | Peritonitis (HP:0002586) | 1.85229514 |
| 136 | Hypoplasia of the thymus (HP:0000778) | 1.83934062 |
| 137 | Hemoptysis (HP:0002105) | 1.83541644 |
| 138 | Chest pain (HP:0100749) | 1.81162350 |
| 139 | Abnormality of the thoracic spine (HP:0100711) | 1.80430812 |
| 140 | Abnormality of the radial head (HP:0003995) | 1.78041992 |
| 141 | Dislocated radial head (HP:0003083) | 1.76667736 |
| 142 | Pulmonary infiltrates (HP:0002113) | 1.75031078 |
| 143 | Deformed sella turcica (HP:0002681) | 1.73032809 |
| 144 | Cervical subluxation (HP:0003308) | 1.72686917 |
| 145 | Mitral valve prolapse (HP:0001634) | 1.71490889 |
| 146 | Macroorchidism (HP:0000053) | 1.70898736 |
| 147 | Absent frontal sinuses (HP:0002688) | 1.70101584 |
| 148 | Coarse hair (HP:0002208) | 1.67190392 |
| 149 | Striae distensae (HP:0001065) | 1.67095669 |
| 150 | Global brain atrophy (HP:0002283) | 1.66005404 |
| 151 | Viral hepatitis (HP:0006562) | 1.65397681 |
| 152 | Aortic regurgitation (HP:0001659) | 1.63866531 |
| 153 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.62279512 |
| 154 | Distal lower limb amyotrophy (HP:0008944) | 1.61563275 |
| 155 | Micronodular cirrhosis (HP:0001413) | 1.61317689 |
| 156 | Vertebral arch anomaly (HP:0008438) | 1.60758663 |
| 157 | Abnormality of oral frenula (HP:0000190) | 1.58606762 |
| 158 | Glucose intolerance (HP:0000833) | 1.58128786 |
| 159 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.58118740 |
| 160 | Joint laxity (HP:0001388) | 1.57811999 |
| 161 | Abnormal glucose tolerance (HP:0001952) | 1.57641911 |
| 162 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.57513517 |
| 163 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.57513517 |
| 164 | Abnormality of glycolipid metabolism (HP:0010969) | 1.57513517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 4.74696866 |
| 2 | FLT3 | 3.96680900 |
| 3 | MAP4K1 | 3.43149214 |
| 4 | ERN1 | 3.22502259 |
| 5 | PRPF4B | 2.94037324 |
| 6 | BLK | 2.91405344 |
| 7 | KIT | 2.86684142 |
| 8 | TBK1 | 2.59100965 |
| 9 | BRSK2 | 2.51845655 |
| 10 | ZAP70 | 2.42915947 |
| 11 | TGFBR2 | 2.39029660 |
| 12 | EEF2K | 2.28940461 |
| 13 | JAK3 | 2.28234996 |
| 14 | TYK2 | 2.24207341 |
| 15 | TGFBR1 | 2.14176465 |
| 16 | PKN2 | 2.12928440 |
| 17 | SCYL2 | 2.09160220 |
| 18 | TESK2 | 1.99314584 |
| 19 | IKBKE | 1.84056884 |
| 20 | TAOK3 | 1.82151077 |
| 21 | TRIB3 | 1.80511316 |
| 22 | EPHB1 | 1.77235315 |
| 23 | TEC | 1.71477070 |
| 24 | CSF1R | 1.65417241 |
| 25 | ICK | 1.62771904 |
| 26 | BTK | 1.57193691 |
| 27 | NME2 | 1.55593428 |
| 28 | MAP3K10 | 1.54474065 |
| 29 | LRRK2 | 1.53280680 |
| 30 | SMG1 | 1.45829883 |
| 31 | CDC42BPA | 1.34459488 |
| 32 | KSR2 | 1.33466201 |
| 33 | FGFR4 | 1.31028920 |
| 34 | TTN | 1.30695696 |
| 35 | IRAK4 | 1.29811001 |
| 36 | MARK3 | 1.28597002 |
| 37 | PRKD2 | 1.27714405 |
| 38 | MAP3K13 | 1.25705459 |
| 39 | STK10 | 1.23985110 |
| 40 | FES | 1.21957521 |
| 41 | JAK1 | 1.21862219 |
| 42 | MAP3K2 | 1.21148325 |
| 43 | EPHA3 | 1.17227579 |
| 44 | SIK2 | 1.16881005 |
| 45 | ACVR1B | 1.15899213 |
| 46 | TXK | 1.15264703 |
| 47 | TRPM7 | 1.14311292 |
| 48 | MAPKAPK3 | 1.14108428 |
| 49 | MAP3K9 | 1.11892492 |
| 50 | CAMKK1 | 1.10363874 |
| 51 | SYK | 1.09570188 |
| 52 | RET | 1.09528282 |
| 53 | LCK | 1.08080287 |
| 54 | BCKDK | 1.06802026 |
| 55 | MAP3K7 | 1.05972923 |
| 56 | MAP3K3 | 1.05236358 |
| 57 | PDGFRB | 1.01987337 |
| 58 | CLK1 | 1.01364192 |
| 59 | PASK | 0.98802093 |
| 60 | PIM2 | 0.98382706 |
| 61 | MAP3K14 | 0.97222869 |
| 62 | PDGFRA | 0.97095723 |
| 63 | MELK | 0.96532306 |
| 64 | STK38 | 0.96380568 |
| 65 | RPS6KA2 | 0.93501032 |
| 66 | CDK12 | 0.91405503 |
| 67 | PDK1 | 0.90703735 |
| 68 | MAP3K1 | 0.90465750 |
| 69 | MAP2K3 | 0.89998238 |
| 70 | PDPK1 | 0.89538746 |
| 71 | ITK | 0.88269716 |
| 72 | TNIK | 0.81942341 |
| 73 | TIE1 | 0.81146133 |
| 74 | MAPK11 | 0.80764323 |
| 75 | PAK4 | 0.79139470 |
| 76 | SGK3 | 0.79029305 |
| 77 | CSK | 0.77823789 |
| 78 | GRK6 | 0.76868168 |
| 79 | DYRK1B | 0.76715977 |
| 80 | PTK6 | 0.75618890 |
| 81 | IRAK1 | 0.75038220 |
| 82 | NLK | 0.75012413 |
| 83 | HCK | 0.74570226 |
| 84 | LYN | 0.73691323 |
| 85 | RPS6KA4 | 0.73681619 |
| 86 | IKBKB | 0.70838843 |
| 87 | RPS6KC1 | 0.70357189 |
| 88 | RPS6KL1 | 0.70357189 |
| 89 | BRSK1 | 0.69429271 |
| 90 | JAK2 | 0.69123690 |
| 91 | BRD4 | 0.69027131 |
| 92 | NEK2 | 0.68522824 |
| 93 | YES1 | 0.67633123 |
| 94 | KSR1 | 0.66983344 |
| 95 | PRKG2 | 0.66310129 |
| 96 | TYRO3 | 0.66143156 |
| 97 | CAMKK2 | 0.65756464 |
| 98 | RPS6KA6 | 0.65468694 |
| 99 | MTOR | 0.64756811 |
| 100 | EPHA2 | 0.64409500 |
| 101 | MAPK15 | 0.62659654 |
| 102 | TAOK1 | 0.61913579 |
| 103 | MATK | 0.61654959 |
| 104 | SGK2 | 0.61385398 |
| 105 | CDK8 | 0.60691241 |
| 106 | MAPK7 | 0.60236150 |
| 107 | CAMK1D | 0.58411776 |
| 108 | MAP3K6 | 0.57884362 |
| 109 | FGFR3 | 0.57787781 |
| 110 | MARK2 | 0.57029856 |
| 111 | MUSK | 0.56517012 |
| 112 | WNK1 | 0.53338650 |
| 113 | GRK1 | 0.53333272 |
| 114 | MAPK12 | 0.53313785 |
| 115 | MAPK4 | 0.50261760 |
| 116 | MAP3K11 | 0.50077368 |
| 117 | CDK6 | 0.49861370 |
| 118 | RPS6KB2 | 0.48462154 |
| 119 | NEK6 | 0.48426008 |
| 120 | SIK1 | 0.47094915 |
| 121 | PIK3CA | 0.46236534 |
| 122 | VRK1 | 0.42525987 |
| 123 | MYLK | 0.41038655 |
| 124 | CDK9 | 0.40935030 |
| 125 | TESK1 | 0.37645489 |
| 126 | MAP2K6 | 0.35958741 |
| 127 | STK16 | 0.33866318 |
| 128 | ATR | 0.33806979 |
| 129 | CHUK | 0.33462709 |
| 130 | PIM1 | 0.33433717 |
| 131 | TNK2 | 0.32757934 |
| 132 | DAPK1 | 0.32380724 |
| 133 | RIPK1 | 0.30559892 |
| 134 | CDK4 | 0.29345228 |
| 135 | MAPKAPK2 | 0.28494477 |
| 136 | RIPK4 | 0.26116752 |
| 137 | IRAK3 | 0.25431816 |
| 138 | PRKCH | 0.24801014 |
| 139 | NEK9 | 0.24687448 |
| 140 | HIPK2 | 0.23764129 |
| 141 | RAF1 | 0.22547300 |
| 142 | MAP3K12 | 0.22466513 |
| 143 | SIK3 | 0.21149824 |
| 144 | MAP2K2 | 0.21090817 |
| 145 | PRKCD | 0.20598779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.39341994 |
| 2 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.54301629 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.30045590 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.09221776 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.07377198 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.06688618 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.04816058 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.04553966 |
| 9 | Phototransduction_Homo sapiens_hsa04744 | 2.02911363 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.93197516 |
| 11 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.90706940 |
| 12 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.88764308 |
| 13 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.86925029 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.69711399 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.69489922 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.69182697 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60807280 |
| 18 | DNA replication_Homo sapiens_hsa03030 | 1.60746388 |
| 19 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.58102237 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.57895148 |
| 21 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.56536442 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.55836703 |
| 23 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.50993653 |
| 24 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.49621275 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.48666659 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.48508507 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47962659 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.47947706 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.47054955 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.46473845 |
| 31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.46318441 |
| 32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.43148910 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.41664941 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.39336689 |
| 35 | Endometrial cancer_Homo sapiens_hsa05213 | 1.38364838 |
| 36 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.37299883 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35348177 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.34465750 |
| 39 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.33108719 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33105545 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28956792 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.28409446 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.26314934 |
| 44 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.24771833 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.24455722 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.20995758 |
| 47 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.20079989 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.19112856 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.17838648 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16875509 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.14024074 |
| 52 | Insulin resistance_Homo sapiens_hsa04931 | 1.11726963 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 1.11528169 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.10827318 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.10012648 |
| 56 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.06060696 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.05082286 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 1.04758363 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.02991806 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01492172 |
| 61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.01253835 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.99564855 |
| 63 | Focal adhesion_Homo sapiens_hsa04510 | 0.99042796 |
| 64 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98781482 |
| 65 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.97835252 |
| 66 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.96809707 |
| 67 | Prostate cancer_Homo sapiens_hsa05215 | 0.95668746 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.95171159 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94621591 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 0.94596800 |
| 71 | Colorectal cancer_Homo sapiens_hsa05210 | 0.93955947 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.93583757 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93364160 |
| 74 | RNA degradation_Homo sapiens_hsa03018 | 0.93142831 |
| 75 | Glioma_Homo sapiens_hsa05214 | 0.93035573 |
| 76 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.92168326 |
| 77 | Influenza A_Homo sapiens_hsa05164 | 0.92136890 |
| 78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.92125734 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91843545 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.91586728 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.90815352 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.88149893 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.87816062 |
| 84 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87751092 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87174973 |
| 86 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.87047116 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85993865 |
| 88 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.84906501 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.83921249 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83727339 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.83283950 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83169445 |
| 93 | Thyroid cancer_Homo sapiens_hsa05216 | 0.82826848 |
| 94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82533961 |
| 95 | Protein export_Homo sapiens_hsa03060 | 0.82006293 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.81837823 |
| 97 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.81447521 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80423545 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79784528 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79423688 |
| 101 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.78993162 |
| 102 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78367583 |
| 103 | Allograft rejection_Homo sapiens_hsa05330 | 0.78038593 |
| 104 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.77645991 |
| 105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.76798929 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75771619 |
| 107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75151791 |
| 108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75093730 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74817752 |
| 110 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.74105469 |
| 111 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74051404 |
| 112 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73065332 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.72757627 |
| 114 | Adherens junction_Homo sapiens_hsa04520 | 0.71007251 |
| 115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70923113 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.69595283 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.68550261 |
| 118 | Carbon metabolism_Homo sapiens_hsa01200 | 0.68349602 |
| 119 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.67839230 |
| 120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67059113 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.66392422 |
| 122 | Malaria_Homo sapiens_hsa05144 | 0.66306367 |
| 123 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66132053 |
| 124 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65964288 |
| 125 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65662588 |
| 126 | Bladder cancer_Homo sapiens_hsa05219 | 0.64908023 |
| 127 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64869230 |
| 128 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64823705 |
| 129 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64341151 |
| 130 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64301795 |
| 131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63838607 |
| 132 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61174664 |
| 133 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60718315 |
| 134 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60188236 |
| 135 | Spliceosome_Homo sapiens_hsa03040 | 0.59279115 |
| 136 | Platelet activation_Homo sapiens_hsa04611 | 0.58601509 |
| 137 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.58077011 |
| 138 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57821926 |
| 139 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57809516 |
| 140 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.57686854 |
| 141 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56743156 |
| 142 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54600168 |
| 143 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54585605 |
| 144 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54359349 |
| 145 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54022802 |
| 146 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51469799 |
| 147 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47438636 |
| 148 | Mismatch repair_Homo sapiens_hsa03430 | 0.47264653 |
| 149 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46700428 |
| 150 | Lysine degradation_Homo sapiens_hsa00310 | 0.46175982 |
| 151 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45092277 |
| 152 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44352692 |
| 153 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.43115915 |
| 154 | Hepatitis C_Homo sapiens_hsa05160 | 0.43029653 |
| 155 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42604552 |

